Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases

AIM: Therapeutic targeting of BRAF alterations in primary brain tumor patients has demonstrated clinical activity in case reports and early trials; however, there is limited high-level evidence of the efficacy. PATIENTS & RESULTS: Targeting BRAF V600E mutations with concurrent dabrafenib and tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith-Cohn, Matthew, Davidson, Christian, Colman, Howard, Cohen, Adam L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912849/
https://www.ncbi.nlm.nih.gov/pubmed/31818130
http://dx.doi.org/10.2217/cns-2019-0018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912849/
https://www.ncbi.nlm.nih.gov/pubmed/31818130
http://dx.doi.org/10.2217/cns-2019-0018

Ejemplares similares